Health X Platform Ltd (BOM:533259)

Q4 2025 Sastasundar Ventures Ltd Earnings Call Transcript

Jun 12, 2025 / 10:00 AM GMT

Release Date Price: ₹281.4 (-1.69%)

Transcript

Key Points

Positve

Sastasundar Ventures Ltd (BOM:533259) successfully relaunched its B2C initiative, now housed in a 100% owned subsidiary, showing strong momentum.
The company has nearly doubled its B2B revenue from INR 4,924 crore to approximately INR 941 crore by the end of the financial year.
The company has launched a new channel for generic medicine under the brand 'Gito', offering customers discounts up to 60% on quality generic medicines.
Sastasundar Ventures Ltd (BOM:533259) has integrated diagnostic services into its app, gaining good traction and enhancing customer engagement.
The company has significantly reduced its working capital days from 35 to 23, indicating improved operational efficiency.

Negative

The strategic shift away from the Flipkart-linked health model resulted in a temporary dip in margins and a negative EBITDA for the year.
The B2C revenue of INR 144 crore for FY25 was below earlier projections due to the early closure of Flipkart Health operations.
There is regulatory uncertainty regarding e-pharmacy operations in India, which poses a potential risk to the business model.
The diagnostic vertical remains a small part of the overall portfolio, contributing only INR 3 crore in FY25, indicating limited current impact.
The company is in a startup phase, which involves execution risks and the need for significant investment in building business blocks.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

SAST.NS - Sastasundar Ventures Ltd
Q4 2025 Sastasundar Ventures Ltd Earnings Call
Jun 12, 2025 / 10:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to the Sata Sundar Ventures Limited Q4 and FI 25 earnings conference call. As a reminder, all participant 9 will be in listen-only mode, and there will be an opportunity for you to ask questions after the presentation.

Should you need assistance during the conference call, please signal an operator by pressing start and 0 on your touchstone phone. Please note that this conference is being recorded.

I now hand the conference over to Ms. Raji Amre from NUFT Investor relations team.

Thank you and over to you, ma'am.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.